[Congressional Record Volume 161, Number 48 (Monday, March 23, 2015)]
[Extensions of Remarks]
[Page E380]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




                     RECOGNIZING DR. SPIRO SPIREAS

                                 ______
                                 

                      HON. MICHAEL G. FITZPATRICK

                            of pennsylvania

                    in the house of representatives

                         Monday, March 23, 2015

  Mr. FITZPATRICK. Mr. Speaker, I rise today to honor Dr. Spiro 
Spireas, a local resident who serves as the Chairman of the Board and 
Chief Executive Officer of Sigmapharm Laboratories. Dr. Spireas founded 
Sigmapharm Laboratories in 2005. He is the inventor and author of more 
than 70 international and domestic patents and 200 scientific papers, 
books, and other publications in the fields of industrial pharmacy, 
biopharmaceutics, pharmacokinetics, pharmaceutical technology and 
analytical chemistry.
  He holds Ph.D. and M.S. degrees in Pharmaceutics and Industrial 
Pharmacy from St. John's University, and a B.S. in Pharmacy from the 
Hellenic National University of Athens, Greece. Prior to forming 
Sigmapharm Laboratories, Dr. Spireas served for 6 years as the Vice 
President of Research and Development for URL Pharma, Inc. At URL 
Pharma, he developed various unique products including Felodipine 
extended release tablets, which remained for several years as the only 
marketed generic equivalent to Astra Zeneca's Plendil ER tablets.
  In addition, Dr. Spireas taught several graduate and undergraduate 
courses of pharmaceutical sciences and conducted extensive research 
producing more than 20 Ph.D. and M.S. dissertations as a Professor of 
Pharmacy and Pharmaceutical Technology at the Arnold & Marie Schwartz 
College of Pharmacy of Long Island University. Several of his graduate 
students went on to work with Dr. Spireas at Sigmapharm, and have 
helped shape the company into what it is today. Dr. Spireas embodies an 
entrepreneurial and innovative spirit that is unmatched. His 
contributions to the pharmaceutical industry are greatly admired and 
appreciated by myself, and my constituents. Dr. Spireas has helped 
develop products that save lives and keep us healthy, while training a 
new, young, and eager workforce ready to make contributions to the 
betterment of society.
  It is an honor and privilege to recognize Dr. Spireas today. I wish 
him the best of luck in his future endeavors.

                          ____________________